| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
42,589 |
41,652 |
$70.09M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
29,231 |
28,256 |
$51.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
72,904 |
71,913 |
$46.52M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
83,958 |
82,773 |
$30.80M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,887 |
6,639 |
$15.11M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
181,005 |
165,471 |
$8.38M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
29,606 |
29,253 |
$5.87M |
| G0378 |
Hospital observation service, per hour |
2,757 |
1,362 |
$4.60M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
5,569 |
745 |
$4.46M |
| 87631 |
|
24,377 |
23,960 |
$4.10M |
| 93000 |
|
16,712 |
16,056 |
$3.89M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12,955 |
9,321 |
$3.66M |
| 93325 |
|
6,851 |
6,445 |
$3.49M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
5,543 |
5,211 |
$3.46M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,802 |
1,702 |
$2.95M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
50,285 |
48,898 |
$2.92M |
| 93320 |
|
5,607 |
5,257 |
$2.49M |
| 94010 |
|
5,294 |
5,123 |
$1.75M |
| 71046 |
Radiologic examination, chest; 2 views |
36,315 |
35,486 |
$1.62M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,432 |
1,398 |
$1.46M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,527 |
3,620 |
$1.37M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
356 |
350 |
$1.37M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,697 |
2,618 |
$1.28M |
| 76770 |
|
5,389 |
5,202 |
$766K |
| 87506 |
|
2,190 |
2,137 |
$663K |
| 74018 |
|
15,737 |
15,191 |
$622K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,088 |
9,080 |
$508K |
| 92567 |
|
12,466 |
12,250 |
$502K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
56,265 |
50,545 |
$484K |
| 84145 |
|
14,766 |
14,196 |
$451K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
288 |
257 |
$409K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
215 |
212 |
$381K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,768 |
5,715 |
$377K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,143 |
3,001 |
$368K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17,084 |
16,876 |
$349K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,663 |
4,576 |
$348K |
| 80053 |
Comprehensive metabolic panel |
26,929 |
25,528 |
$334K |
| 96137 |
|
351 |
259 |
$328K |
| 92579 |
|
2,986 |
2,949 |
$316K |
| 86141 |
|
21,121 |
20,269 |
$310K |
| 90791 |
Psychiatric diagnostic evaluation |
1,334 |
1,309 |
$294K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
5,238 |
4,295 |
$287K |
| 87428 |
|
3,994 |
3,937 |
$284K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
29,465 |
28,715 |
$282K |
| J3490 |
Unclassified drugs |
4,669 |
2,767 |
$269K |
| 44970 |
|
56 |
52 |
$257K |
| J3480 |
Injection, potassium chloride, per 2 meq |
4,456 |
3,441 |
$253K |
| 96116 |
|
629 |
607 |
$226K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
141 |
137 |
$198K |
| 87040 |
|
15,793 |
15,164 |
$191K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,268 |
4,936 |
$181K |
| 96133 |
|
308 |
256 |
$176K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,060 |
1,035 |
$162K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
162 |
159 |
$152K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
9,520 |
4,879 |
$143K |
| 92582 |
|
1,329 |
1,314 |
$142K |
| 81003 |
|
51,292 |
49,723 |
$130K |
| 95716 |
|
36 |
26 |
$115K |
| 87081 |
|
12,870 |
12,720 |
$107K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,058 |
1,932 |
$105K |
| 31624 |
|
41 |
40 |
$103K |
| 94644 |
|
754 |
720 |
$103K |
| 96132 |
|
275 |
263 |
$102K |
| 90670 |
|
184 |
175 |
$101K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,162 |
2,264 |
$91K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
343 |
335 |
$88K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,379 |
1,239 |
$84K |
| 86850 |
|
597 |
537 |
$81K |
| 71045 |
Radiologic examination, chest; single view |
2,299 |
2,217 |
$80K |
| 17110 |
|
954 |
936 |
$77K |
| 92555 |
|
3,776 |
3,745 |
$72K |
| 94760 |
|
12,061 |
11,698 |
$63K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
151 |
149 |
$63K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
3,406 |
3,185 |
$56K |
| 96409 |
|
296 |
110 |
$55K |
| 51798 |
|
438 |
425 |
$49K |
| 96158 |
|
323 |
218 |
$47K |
| 96121 |
|
143 |
143 |
$45K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,031 |
3,707 |
$43K |
| 96136 |
|
203 |
189 |
$43K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,290 |
4,768 |
$38K |
| 77075 |
|
316 |
278 |
$38K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$37K |
| 97760 |
|
885 |
839 |
$37K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,729 |
2,645 |
$37K |
| 96159 |
|
274 |
187 |
$33K |
| 77072 |
|
976 |
961 |
$32K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
13 |
13 |
$32K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,472 |
2,354 |
$30K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,191 |
1,963 |
$29K |
| 93886 |
|
100 |
98 |
$27K |
| 87581 |
|
886 |
881 |
$25K |
| 76000 |
|
485 |
459 |
$22K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
841 |
562 |
$21K |
| 72082 |
|
217 |
217 |
$20K |
| 99201 |
|
265 |
256 |
$18K |
| 83021 |
|
1,001 |
922 |
$18K |
| 97161 |
|
113 |
113 |
$16K |
| 92588 |
|
153 |
150 |
$16K |
| 88304 |
|
117 |
111 |
$16K |
| 88342 |
|
55 |
54 |
$15K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,069 |
1,828 |
$14K |
| 85045 |
|
3,408 |
2,929 |
$14K |
| 82947 |
|
3,058 |
2,522 |
$14K |
| 92552 |
|
212 |
210 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,178 |
1,122 |
$13K |
| 93308 |
|
26 |
26 |
$12K |
| 93321 |
|
37 |
37 |
$11K |
| 87077 |
|
1,237 |
1,188 |
$11K |
| 74019 |
|
205 |
203 |
$11K |
| 82728 |
|
778 |
716 |
$10K |
| 81025 |
|
1,140 |
1,105 |
$10K |
| 86902 |
|
387 |
293 |
$9K |
| 81015 |
|
11,688 |
11,407 |
$9K |
| 83690 |
|
1,182 |
1,108 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
810 |
797 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
139 |
52 |
$7K |
| 85046 |
|
1,055 |
968 |
$7K |
| 51741 |
|
26 |
26 |
$7K |
| 95700 |
|
16 |
15 |
$7K |
| 70360 |
|
161 |
159 |
$7K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
897 |
854 |
$6K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
24 |
12 |
$6K |
| 31575 |
|
27 |
26 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
71 |
25 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
38 |
36 |
$5K |
| J0290 |
Injection, ampicillin sodium, 500 mg |
66 |
38 |
$5K |
| 29130 |
|
36 |
35 |
$5K |
| 97165 |
|
35 |
34 |
$5K |
| 0002A |
|
301 |
300 |
$5K |
| 88108 |
|
41 |
40 |
$5K |
| 93975 |
|
12 |
12 |
$4K |
| 80076 |
|
498 |
467 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
89 |
72 |
$4K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
193 |
187 |
$4K |
| 82805 |
|
72 |
39 |
$4K |
| 82803 |
|
172 |
144 |
$4K |
| 92553 |
|
50 |
50 |
$3K |
| 74455 |
|
30 |
29 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
12 |
12 |
$3K |
| 85027 |
|
573 |
475 |
$3K |
| 72141 |
|
12 |
12 |
$3K |
| 80069 |
|
1,305 |
860 |
$3K |
| 83880 |
|
72 |
65 |
$3K |
| 0001A |
|
313 |
311 |
$3K |
| 87070 |
|
371 |
352 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
59 |
57 |
$3K |
| 92630 |
|
29 |
14 |
$3K |
| 92593 |
|
25 |
24 |
$3K |
| 93788 |
|
14 |
14 |
$2K |
| 82977 |
|
328 |
306 |
$2K |
| 85007 |
|
621 |
523 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$2K |
| 36430 |
|
164 |
147 |
$2K |
| 83655 |
|
198 |
179 |
$2K |
| 84703 |
|
221 |
218 |
$2K |
| 82565 |
|
363 |
327 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
170 |
122 |
$2K |
| 86900 |
|
588 |
529 |
$2K |
| 82247 |
|
413 |
294 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
48 |
39 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
48 |
39 |
$2K |
| 93786 |
|
14 |
14 |
$2K |
| 83605 |
|
187 |
146 |
$1K |
| 76536 |
|
14 |
12 |
$1K |
| 73090 |
|
40 |
39 |
$1K |
| 84460 |
|
261 |
199 |
$1K |
| 87205 |
|
382 |
358 |
$1K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
211 |
209 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
33 |
27 |
$1K |
| 83735 |
|
721 |
471 |
$1K |
| 74220 |
|
12 |
12 |
$1K |
| 82150 |
|
178 |
168 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
943 |
683 |
$1K |
| 82248 |
|
420 |
281 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
16 |
13 |
$995.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
15 |
12 |
$986.81 |
| 73521 |
|
24 |
24 |
$975.86 |
| 84484 |
|
76 |
68 |
$960.22 |
| 80061 |
Lipid panel |
55 |
55 |
$957.48 |
| 83615 |
|
148 |
131 |
$914.88 |
| 90461 |
|
563 |
504 |
$831.69 |
| 88313 |
|
12 |
12 |
$824.84 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
785 |
684 |
$795.11 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
55 |
49 |
$785.24 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
19 |
14 |
$775.54 |
| J7070 |
Infusion, d5w, 1000 cc |
18 |
14 |
$762.42 |
| 73610 |
|
14 |
13 |
$749.55 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
217 |
216 |
$736.28 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
25 |
25 |
$608.34 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
39 |
27 |
$432.54 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
60 |
49 |
$428.19 |
| V5020 |
Conformity evaluation |
12 |
12 |
$413.54 |
| S5010 |
5% dextrose and 0.45% normal saline, 1000 ml |
13 |
13 |
$410.19 |
| 62270 |
|
41 |
38 |
$367.31 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
109 |
100 |
$367.18 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
16 |
13 |
$364.04 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
94 |
94 |
$339.89 |
| 82272 |
|
63 |
63 |
$335.85 |
| 82945 |
|
200 |
195 |
$327.90 |
| 84450 |
|
48 |
48 |
$324.81 |
| 82330 |
|
52 |
39 |
$314.77 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
27 |
26 |
$294.11 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
26 |
13 |
$293.56 |
| 85347 |
|
56 |
39 |
$287.10 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
18 |
13 |
$283.54 |
| 84466 |
|
17 |
17 |
$275.99 |
| 82570 |
|
108 |
102 |
$264.34 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
24 |
13 |
$228.92 |
| 86160 |
|
13 |
12 |
$212.88 |
| 85651 |
|
40 |
40 |
$205.94 |
| 87799 |
|
61 |
54 |
$197.91 |
| 87497 |
|
31 |
29 |
$179.95 |
| 83825 |
|
14 |
12 |
$153.79 |
| 82043 |
|
24 |
24 |
$152.24 |
| 83540 |
|
17 |
17 |
$139.73 |
| 87184 |
|
26 |
25 |
$138.16 |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
12 |
12 |
$129.51 |
| 84157 |
|
40 |
38 |
$120.96 |
| 85610 |
|
48 |
39 |
$119.52 |
| 85730 |
|
26 |
24 |
$106.05 |
| 85018 |
|
67 |
39 |
$104.60 |
| 83970 |
|
97 |
94 |
$104.04 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
12 |
12 |
$100.89 |
| 80197 |
|
202 |
112 |
$80.71 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
40 |
38 |
$74.58 |
| 84550 |
|
13 |
12 |
$68.24 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
119 |
118 |
$67.20 |
| A4218 |
Sterile saline or water, metered dose dispenser, 10 ml |
33 |
32 |
$63.99 |
| 84295 |
|
22 |
15 |
$61.17 |
| 84132 |
|
22 |
15 |
$60.59 |
| 84156 |
|
16 |
15 |
$47.37 |
| 85008 |
|
845 |
642 |
$12.70 |
| 85014 |
|
22 |
15 |
$12.49 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
117 |
117 |
$2.33 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
38 |
38 |
$0.00 |
| 83520 |
|
18 |
16 |
$0.00 |
| 83550 |
|
17 |
17 |
$0.00 |